Tobramycin(Naryx Pharma)

N/A

Report date: 2024/09/06 20:00:43

Base Information

Drug NameTobramycin(Naryx Pharma)
Drug Alias NameSybryxSPRC-AB01
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of Action30S ribosomal subunit inhibitors
Targets30S ribosomal subunit
Therapy Area/IndicationsSinusitis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesNaryx Pharma Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNaryx Pharma
Active IndicationsN/A
Inactive IndicationsSinusitis

Other Information

ATC CodeN/A
Related LinksN/A